Williams L S, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, Fineberg S E, Tierney W R
Roudebush VA Medical Center, Indiana University School of Medicine, Indianapolis 46202, USA.
Neurology. 2002 Jul 9;59(1):67-71. doi: 10.1212/wnl.59.1.67.
Hyperglycemia at the time of acute ischemic stroke has been linked to worse outcome in both human and animal studies.
To describe the prevalence and severity of hyperglycemia on hospital admission among acute ischemic stroke patients, to examine the independent relationship of admission hyperglycemia to all-cause mortality, and to document the inpatient management of hyperglycemia.
Patients hospitalized with acute ischemic stroke at one hospital from July 1993 to June 1998 (n = 656) were identified. Demographic data, diagnoses, and blood glucose (BG) values were retrieved from the electronic medical record system. Admission stroke severity, fingerstick BG results, and new diabetes diagnoses were obtained by chart review. Hyperglycemia was defined as admitting random serum BG > or = 130 mg/dL. Hazard ratios (HR) for 30-day, 1-year, and 6-year mortality were calculated using multivariable Cox regression models.
Hyperglycemia at admission to hospital was present in 40% of patients with acute stroke. Patients with hyperglycemia were more often women and more likely to have prior diagnoses of diabetes and heart failure. Almost all of these patients remained hyperglycemic during their hospital stay (mean BG = 206 mg/dL), and 43% received no inpatient hypoglycemic drugs. Hyperglycemic patients had longer hospital stay (7 vs 6 days, p = 0.015) and higher inpatient hospital charges ($6,611 vs $5,262, p < 0.001). Hyperglycemia independently increased the risk for death at 30 days (HR 1.87, p < or = 0.01), 1 year (HR 1.75, p < or = 0.01), and 6 years after stroke (HR 1.41, p </= 0.01).
Admitting hyperglycemia was common among patients with acute ischemic stroke and was associated with increased short- and long-term mortality and with increased inpatient charges. Inpatient blood glucose management was suboptimal in this hospital. A trial of intensive treatment of hyperglycemia should be considered.
在人类和动物研究中,急性缺血性卒中发生时的高血糖与较差的预后相关。
描述急性缺血性卒中患者入院时高血糖的患病率及严重程度,研究入院时高血糖与全因死亡率的独立关系,并记录高血糖的住院治疗情况。
确定1993年7月至1998年6月在一家医院住院的急性缺血性卒中患者(n = 656)。从电子病历系统中获取人口统计学数据、诊断信息和血糖(BG)值。通过病历审查获得入院时卒中严重程度、指尖血糖结果和新诊断的糖尿病。高血糖定义为入院时随机血清BG≥130mg/dL。使用多变量Cox回归模型计算30天、1年和6年死亡率的风险比(HR)。
40%的急性卒中患者入院时存在高血糖。高血糖患者女性更多,更有可能既往诊断为糖尿病和心力衰竭。几乎所有这些患者在住院期间血糖仍高(平均BG = 206mg/dL),43%未接受住院降糖药物治疗。高血糖患者住院时间更长(7天对6天,p = 0.015),住院费用更高(6611美元对5262美元,p < 0.001)。高血糖独立增加卒中后30天(HR 1.87,p≤0.01)、1年(HR 1.75,p≤0.01)和6年(HR 1.41,p≤0.01)死亡风险。
急性缺血性卒中患者入院时高血糖常见,与短期和长期死亡率增加及住院费用增加相关。该医院住院血糖管理欠佳。应考虑进行高血糖强化治疗试验。